Skip to main content
Equibles
GNW logo

GNW · Genworth Financial Inc

Track GNW — free

Use GNW with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about GNW

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$10.16 +0.17 (+1.70%) At close · Aug 14
Market Cap
$3.84B
Shares
377.85M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.16 Open$9.98 Day$9.98–10.17 52W close$7.94–10.16 Avg vol 30d2.8M Short int7.7M · 2.0% float · 2.6d Short vol51% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 9, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very Low
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +15%
      above
      Price vs 50-day avg +7%
      above
      RSI (14) 66
      neutral
      MACD trend Negative
      52-week position 100%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +1%
      trailing
      6-month return +22%
      trailing
      YTD return +13%
      this year
      Relative strength +9%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $10 › 200d $9 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +48 funds added
      Insider flow Distributing
      Net -$1.4M over 90 days · 100% sells
      Short interest Falling
      2.04% of float · ▼ -11.0% MoM · 2.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      363 holders — near 3-yr high, broad support
      Squeeze score 46
      elevated · 0–100
      Fundamentals
      Weak
      Revenue growth +0%
      Y/Y
      EPS growth −21%
      Y/Y
      Valuation P/E 19.2
      in line
      Buyback $128.0M
      remaining
      Balance sheet $1.4B
      net debt
      Quant / Vol
      risk profile
      Very Low
      Volatility 22%
      annualized · 1-yr
      Max drawdown −14%
      past year
      ATR 2.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Jun 30, 2026
      full year 2026
      Capital returns received from Enact $445M – $485M
      CareScout services revenue $25M
      Share repurchases $225M – $250M
      2026
      Investment in CareScout services $50M – $55M
      Prior guidance period ended · from the Earnings Call filed Jun 30, 2024
      Home-care coverage of the age 65-plus census population in the U · end of the year 2024 80% – 85%
      Investment in CareScout services · this year $35M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +15% Bullish
      Price vs 50-day avg
      +7% Bullish
      RSI (14)
      66 Neutral
      MACD trend
      Negative Bearish
      52-week position
      100% Bullish
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $10 › 200d $9 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +48 funds added
      Insider flow Distributing
      Net -$1.4M over 90 days · 100% sells
      Short interest Falling
      2.04% of float · ▼ -11.0% MoM · 2.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      363 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $8 Now $10 · 100% Range high $10
      vs 200-day avg +15% vs 50-day avg +7%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted operating income (loss), excluding Closed Block per diluted share non-GAAP $0.29 Q2 2026 —
      Adjusted operating income (loss), excluding Closed Block per share - Diluted non-GAAP $0.29 Three months ended June 30, 2026 —
      Available Assets Above PMIERs Requirements 1.89B 2Q —
      Care Assurance Worksite approved states 34 Q2 2026 —
      CareScout delivered matches 1,459 Q2 2026 —
      CareScout Services revenues $6M Three months ended June 30, 2026 —
      Direct Primary Risk In-Force 71.62B 2Q —
      Enact adjusted operating income (loss) non-GAAP $143M Q2 2026 —
      New Delinquencies 12,299 2Q —
      Paid Claims 361 2Q —
      Primary Cures 12,278 2Q —
      Primary Delinquencies 24,330 2Q —
      Share repurchases since program inception through June 30, 2026 918M since program inception through June 30, 2026 —
      CareScout Quality Network matches 1,486 Q1 2026 —
      Enact adjusted operating income non-GAAP $140M Q1 2026 —
      LTC MYRAP estimated net present value achieved since 2012 from IFAs 34.5B Q1 2026 —
      Share repurchases since program inception $856M as of March 31, 2026 —
      Adjusted operating income non-GAAP $146M Q4 2025 —
      Adjusted operating income (loss) non-GAAP $8M Q4 2025 —
      CareScout Quality Network matches with home care providers 925 Q4 2025 —
      Enact loss ratio non-GAAP 7% Q4 2025 —
      Gross incremental premium approvals (LTC MYRAP) $100M Q4 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Insurance - Life — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      GNW
      Genworth Financial Inc
      this stock
      		$3.84B +12.5% +0.1% 19.2 2.0%
      CILJF
      China Life Insurance Co Ltd
      		 $97.80B +0.3% — — 0.0%
      MFC
      Manulife Financial Corp
      		 $73.89B +22.5% — — 0.8%
      MET
      Metlife Inc
      		 $62.06B +23.7% +8.6% 18.7 1.8%
      AFL
      Aflac Inc
      		 $60.89B +10.1% -9.3% 13.1 2.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      363
      % held
      86.2%
      Net QoQ
      -7.5M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      324
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      7.7M
      Days to cover
      2.6d
      Change
      -955.1K sh
      View
      Short Volume
      Short vol %
      51%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.1K
      Value
      $10.1K
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      35.9%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$1.4M
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Lisa McClain
      Amount
      $1.0K–$15.0K
      Traded
      Jun 17, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $7.3B
      Net income (FY)
      $223.0M
      EPS diluted
      $0.54
      View
      Buybacks
      Authorized
      $500.0M
      Remaining
      $128.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 6, 2026
      This year
      9
      View
      Proposed Sales
      Value
      $927.0K
      Shares
      100.0K
      Filed
      May 22, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      GNW +4.9% +0.7% +22.4% +3.4% +12.5%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +4.5% -3.8% +8.6% -0.6% -1.3%

      Capital returns

      Buyback program · as of Jul 31, 2026
      Authorized
      $500.00M
      Spent (derived)
      $372.00M
      Remaining
      $128.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1276520 CUSIP 37247D106 13F (30d) 350 filings 347 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)